Gastrectomy: Clinical Trials

46 trials of Gastrectomy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 13 unknown, 7 recruiting, 2 active not recruiting. 9 Not applicable, 9 Phase 2, 9 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable9Unknown 4, Recruiting 3, Completed 2
Phase 29Active not recruiting 2, Completed 2, Unknown 2, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 39Completed 3, Recruiting 3, Unknown 2, Active not recruiting 1
Phase 12Completed 1, Not yet recruiting 1

Follow this drug Literature Review of Gastrectomy trials Research Report on Gastrectomy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
Gastrectomy, Indocyanine Green, Iron Conjugated Polymers in Saline Suspension - Gastric Adenocarcinoma
Phase 1Not yet recruitingM.D. Anderson Cancer Center202026-12-312026-08-14
A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ Adenocarcinoma
Iparomlimab and Tuvonralimab Injection (QL1706), Docetaxel, Oxaliplatin - Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 2Not yet recruitingThe First Affiliated Hospital of Zhengzhou University342026-11-012026-09-18
The Transit Bipartition With the Use of a Metallic Anastomosis Clip and Circular Fundocorporeal Gastroplication
Laparoscopic transit bipartition with Metallic Anastomotic Clip and Circular Fundocorporeal Gastroplication, Laparoscopic transit bipartition (gastroenteroanastomosis and entero-enteric anastomosis) use the Metallic Anastomotic Clip and with sleeve gastrectomy, laparoscopic duodenal transit bipartition using the Metallic Anastomotic Clip with circular fundocorporeal gastroplication without gastrectomy - Type 2 Diabetes Mellitus (T2DM), Obesity & Overweight
Not applicableRecruitingThe Society of Bariatric and Metabolic Surgeons of Kazakhstan902026-04-302026-05-07
Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer
2-4 cycles of neoadjuvant PD-1 Inhibitors combined with chemotherapy, 5-8 cycles of neoadjuvant PD-1 Inhibitors combined with chemotherapy, Gastrectomy - Gastric Adenocarcinoma
CompletedChinese PLA General Hospital4092025-01-162026-10-21
Preventive Use of PIPAC in Locally Advanced Gastric Cancer.
Intervention Group, Control Group - Gastric Cancer
Not applicableRecruitingNational Research Oncology and Transplantology Center, Kazakhstan1602025-01-152025-05-09
Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer
Gastrectomy - Stomach Neoplasm
Not applicableRecruitingAmsterdam UMC6542024-03-012025-09-04
Characterisation of the Intratumoral Microbiome in Gastric Adenocarcinoma: to a Personalised Medicine
Gastrectomy - Gastric Adenocarcinoma
Not applicableUnknownUniversity Hospital, Bordeaux202023-04-222023-04-05
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
Cisplatin, Computed Tomography, Gastrectomy - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Phase 2RecruitingMayo Clinic402023-04-202026-04-08
Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1
Oxaliplatin by arterial infusion plus S-1, SOX neoadjuvant, Sintilimab neoadjuvant - Locally Advanced Gastric Carcinoma
Phase 3RecruitingZhejiang University1902023-03-012026-06-11
Short-term Outcomes of Laparoscopic Versus Open Gastrectomy With Lymph Node Dissection for Early Gastric Cancer :a Randomized Controlled Study
Gastrectomy with lymph node dissection - Early Gastric Cancer
Not applicableUnknownSohag University402023-02-012023-01-31
Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis
Gastrectomy - Gastric Cancer, EBV Infection
CompletedSaint Vincent's Hospital, Korea4602022-08-032022-11-03
Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer
Nivolumab plus SOX, Nivolumab, Gastrectomy - Gastric Cancer, Chemotherapy Effect
Phase 2UnknownChinese PLA General Hospital302022-05-012022-01-11
Gastrectomy Outcomes in Elderly Patients
Gastrectomy - Gastrectomy, Elderly
UnknownMarmara University3502021-11-012021-10-19
Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer
Chemotherapy drug, Gastrectomy, Laparoscopic exploration - Gastric Cancer, Chemotherapy Effect
Phase 3RecruitingChinese PLA General Hospital5242021-01-132021-01-20
Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer
Gastrectomy with D2 lymphadenectomy, Gastrectomy with D2plus lymphadenectomy - Locally Advanced Gastric Cancer
Phase 3RecruitingUniversity of Siena5392018-11-052019-05-23
Multicentric Randomised Trial for Resectable Gastric Cancer
Docetaxel, Oxaliplatin, Capecitabine - Gastric Cancer
Phase 2Active not recruitingThe Netherlands Cancer Institute2072017-12-212024-05-02
Bone Microstructure by Using HR-pQCT in Long Courses After Gastrectomy
gastrectomy - Osteoporosis, Sarcopenia
UnknownKobayashi Shinichiro1142017-09-202018-01-09
The Origin of Infrapyloric Artery
Gastrectomy - Stomach Neoplasm
CompletedPeking University4292017-03-042019-02-19
To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.
Gastrectomy, oxaliplatin, S1 - Gastric Cancer
UnknownShanghai Zhongshan Hospital2282017-01-012022-05-06
PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy
Tegafur-Gimeracil-Oteracil Potassium, Chemoradiotherapy, Gastric resection - Stomach Neoplasm, GastroEsophageal Cancer
Phase 3CompletedShanghai Cancer Hospital, China2042016-12-012025-12-08

Showing 20 of 46. Sign in to see all of them.

Conditions studied

Stomach Neoplasms (28)  ·  Obesity (3)  ·  Adenocarcinoma (2)  ·  Adenocarcinoma Of Esophagus (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Sarcopenia (2)  ·  Anastomotic Leak (1)  ·  Coitus (1)  ·  Diabetes Mellitus (1)  ·  Epstein-Barr Virus Infections (1)  ·  Esophageal Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Hypertension (1)  ·  Margins of Excision (1)  ·  Motor Activity (1)

Sponsors

Chinese PLA General Hospital (5)  ·  University of Bologna (3)  ·  Laval University (2)  ·  Peking University (2)  ·  Yonsei University (2)  ·  Amsterdam UMC (1)  ·  Australasian Gastro-Intestinal Trials Group (1)  ·  Bezmialem Vakif University (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  First Affiliated Hospital, Sun Yat-Sen University (1)  ·  Gulhane Training and Research Hospital (1)  ·  Haruhiko Fukuda (1)  ·  Japan Clinical Oncology Group (1)  ·  Kobayashi Shinichiro (1)  ·  Kocaeli Derince Education and Research Hospital (1)

Countries

China (12)  ·  Italy (5)  ·  South Korea (5)  ·  Turkey (Türkiye) (4)  ·  Canada (3)  ·  France (3)  ·  Germany (3)  ·  Japan (3)  ·  Netherlands (3)  ·  United States (3)  ·  Belgium (2)  ·  Kazakhstan (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Australia (1)

Top investigators

Agnieszka Fronczek, MD (1)  ·  Anna Brzozowska, MD, PhD (1)  ·  Anna Dorothea Wagner, MD (1)  ·  Bruno Nardo, MD,PhD (1)  ·  Ewa Kurys-Denis, MD, PhD (1)  ·  Franco Roviello (1)  ·  Grzegorz Wallner, Professor (1)  ·  Hiroshi Furukawa, MD, PhD (1)  ·  Jian-Kun Hu, M.D. Ph.D. (1)  ·  John V Reynolds, MCh FRCS (1)  ·  Katrine Brodersen, PhD student (1)  ·  Kyong Hwa Jun, Ph.D. (1)

Results publications

PMID 40340830, PMID 11547741, PMID 17462405, PMID 21160814, PMID 21336855, PMID 27486629, PMID 28501086, PMID 28796017, PMID 29413875, PMID 30200910, PMID 30373600, PMID 30496443, PMID 30510361, PMID 31126258, PMID 31221115, PMID 31928530, PMID 35602919, PMID 36589629, PMID 37016303, PMID 38020201, PMID 39282905, PMID 41218205

NIH funding

2014 (1), 2015 (1), U10CA032102 (1)